News
Indian Immunologicals hands over first lot of Covaxin drug substance to Bharat Biotech
To augment the capacity of covid-19 vaccine production in the country, the central government requested that Indian Immunologicals Ltd (IIL) and Bharat Biotech International Limited (BBIL) join hands in April 2021.
